enrofloxacin has been researched along with nalidixic acid in 33 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (9.09) | 18.2507 |
2000's | 23 (69.70) | 29.6817 |
2010's | 6 (18.18) | 24.3611 |
2020's | 1 (3.03) | 2.80 |
Authors | Studies |
---|---|
Catalan, A; de la Campa, AG; Dominguez, L; Escudero, JA; Gonzalez-Zorn, B; Lopez, G; Moreno, MA; Rivero, E; San Millan, A | 1 |
Aarflot, L; Colquhoun, DJ; Melvold, CF | 1 |
Arakawa, Y; Kato, H; Kimura, K; Konda, T; Shibata, N; Shibayama, K; Suzuki, S; Wachino, J; Yamane, K | 1 |
Al-Momani, W; Antunes, NT; Assunção, P; Ayling, RD; Mercier, P; Poveda, JB; Rosales, RS; Tavío, MM | 1 |
Abouzeed, YM; Baucheron, S; Cloeckaert, A | 1 |
Arakawa, Y; Chen, L; Chen, ZL; Deng, YT; Gao, JH; Liu, JH; Zeng, ZL | 1 |
Cattoir, V; Espinal, P; Nordmann, P; Poirel, L; Silva-Sanchez, J | 1 |
Cattoir, V; Nordmann, P; Poirel, L | 1 |
Accogli, M; Caprioli, A; Carattoli, A; Cerquetti, M; Fortini, D; García-Fernández, A; Giufrè, M; Graziani, C; Luzzi, I | 1 |
Dionisi, AM; Lucarelli, C; Luzzi, I; Owczarek, S; Villa, L | 1 |
Caddick, JM; Gunell, M; Hakanen, AJ; Huovinen, P; Jalava, J; Kotilainen, P; Lilly, AJ; Piddock, LJ; Siitonen, A; Webber, MA | 1 |
Chavda, K; Drlica, K; Hoatam, G; Kerns, RJ; Malik, M | 1 |
Bavari, S; Bowlin, TL; Houseweart, C; Moir, DT; Opperman, TJ; Panchal, RG; Peet, NP; Williams, JD | 1 |
Chen, S; Chen, Z; Deng, Y; Huang, X; Liu, JH; Liu, Y; Sun, Y; Tian, W; Wu, C; Zeng, Z; Zhao, J | 1 |
Gozalbes, R; Pineda-Lucena, A | 1 |
Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
Griggs, DJ; Hall, MC; Jin, YF; Piddock, LJ | 1 |
Asuquo, AE; Jin, YF; Piddock, LJ; Ricci, V | 1 |
Helmuth, R; Malorny, B; Schroeter, A | 1 |
Chaslus-Dancla, E; Cloeckaert, A; Dho-Moulin, M; Flaujac, G; Giraud, E; Leroy-Sétrin, S | 1 |
Barry, J; Egan, J; Hill, M; McFaddyen, S; McNamara, E; Murphy, TM; O'Connell, A; O'Loughlin, J; Rooney, N | 1 |
Cid, D; de la Fuente, R; Díez, R; Martínez, S; Orden, JA; Ruiz-Santa-Quiteria, JA | 1 |
Pedersen, K; Wedderkopp, A | 1 |
Lin, J; Luo, N; Michel, LO; Sahin, O; Zhang, Q | 1 |
Avrain, L; Humbert, F; Kempf, I; L'Hospitalier, R; Sanders, P; Vernozy-Rozand, C | 1 |
Delsol, AA; Roe, JM; Woodward, MJ | 1 |
Chang, CF; Chang, YF; Huang, TM | 1 |
Cebula, TA; Levy, DD; Sharma, B | 1 |
Beaudeau, F; Belloc, C; Lam, DN; Laval, A; Pellerin, JL | 1 |
Asai, T; Ishihara, K; Kojima, A; Kubota, S; Negishi, H; Satake, S; Sawada, T; Takahashi, T; Takayama, S; Tamura, Y; Yamamoto, T | 1 |
Lucchi, A; Manfreda, G; Pasquali, F | 1 |
Becker, R; Huang, Y; Kaspar, H; Mankertz, J; Michael, GB; Runge, M; Schwarz, S; Steinhagen, D | 1 |
Grafl, B; Hess, C; Hess, M; Maegdefrau, M | 1 |
33 other study(ies) available for enrofloxacin and nalidixic acid
Article | Year |
---|---|
First characterization of fluoroquinolone resistance in Streptococcus suis.
Topics: Amino Acid Sequence; DNA Gyrase; DNA Topoisomerase IV; Drug Resistance, Bacterial; Female; Fluoroquinolones; Genes, Bacterial; Humans; Male; Molecular Sequence Data; Point Mutation; RNA, Ribosomal, 16S; Sequence Alignment; Streptococcus suis | 2007 |
gyrA and parC Mutations and associated quinolone resistance in Vibrio anguillarum serotype O2b strains isolated from farmed Atlantic cod (Gadus morhua) in Norway.
Topics: Animals; Base Sequence; DNA Gyrase; DNA Topoisomerase IV; Drug Resistance, Bacterial; Fish Diseases; Fisheries; Gadus morhua; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Norway; Quinolones; Serotyping; Vibrio; Vibrio Infections | 2007 |
New plasmid-mediated fluoroquinolone efflux pump, QepA, found in an Escherichia coli clinical isolate.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Chitosan; Conjugation, Genetic; DNA, Bacterial; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Humans; Malates; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Reverse Transcriptase Polymerase Chain Reaction; Transformation, Bacterial; Uncoupling Agents | 2007 |
In vitro susceptibilities of Mycoplasma putrefaciens field isolates.
Topics: Anti-Bacterial Agents; France; Humans; Jordan; Lincomycin; Macrolides; Microbial Sensitivity Tests; Mycoplasma; Mycoplasma Infections; Tetracycline Resistance | 2007 |
ramR mutations involved in efflux-mediated multidrug resistance in Salmonella enterica serovar Typhimurium.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Base Sequence; Cattle; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Genes, Bacterial; Genes, MDR; Genetic Complementation Test; Humans; Molecular Sequence Data; Mutation; Phenotype; Repressor Proteins; Reverse Transcriptase Polymerase Chain Reaction; Salmonella typhimurium | 2008 |
Coprevalence of plasmid-mediated quinolone resistance determinants QepA, Qnr, and AAC(6')-Ib-cr among 16S rRNA methylase RmtB-producing Escherichia coli isolates from pigs.
Topics: Animals; Anti-Bacterial Agents; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Proteins; Fluoroquinolones; Methyltransferases; Plasmids; RNA, Ribosomal, 16S; Swine; Swine Diseases | 2008 |
ISEcp1-mediated transposition of qnrB-like gene in Escherichia coli.
Topics: Base Sequence; DNA Transposable Elements; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Proteins; Microbial Sensitivity Tests; Molecular Sequence Data; Quinolones | 2008 |
Plasmid-mediated quinolone resistance pump QepA2 in an Escherichia coli isolate from France.
Topics: Aged; Base Sequence; DNA Primers; DNA, Bacterial; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Female; Fluoroquinolones; France; Genes, Bacterial; Humans; Models, Genetic; Molecular Sequence Data; Plasmids | 2008 |
First report of plasmid-mediated quinolone resistance determinant qnrS1 in an Escherichia coli strain of animal origin in Italy.
Topics: Animals; Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Bacterial; Escherichia coli; Genes, Bacterial; Microbial Sensitivity Tests; Plasmids; Poultry; Poultry Diseases; Quinolones; Salmonella enterica | 2009 |
Characterization of the plasmid-borne quinolone resistance gene qnrB19 in Salmonella enterica serovar Typhimurium.
Topics: Anti-Bacterial Agents; Bacterial Proteins; DNA Transposable Elements; Drug Resistance, Multiple, Bacterial; Evolution, Molecular; Microbial Sensitivity Tests; Multigene Family; Plasmids; Quinolones; Salmonella typhimurium | 2009 |
Mechanisms of resistance in nontyphoidal Salmonella enterica strains exhibiting a nonclassical quinolone resistance phenotype.
Topics: Bacterial Proteins; Drug Resistance, Bacterial; Electroporation; Genotype; Microbial Sensitivity Tests; Plasmids; Polymerase Chain Reaction; Quinolones; Salmonella enterica | 2009 |
Novel approach for comparing the abilities of quinolones to restrict the emergence of resistant mutants during quinolone exposure.
Topics: Anti-Bacterial Agents; Antimutagenic Agents; Bacteria; Base Sequence; Culture Media; Drug Resistance, Bacterial; Escherichia coli; Fluoroquinolones; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Nalidixic Acid; Topoisomerase II Inhibitors | 2010 |
Efflux-mediated bis-indole resistance in Staphylococcus aureus reveals differential substrate specificities for MepA and MepR.
Topics: Bacterial Proteins; Drug Resistance, Bacterial; Indoles; Microbial Sensitivity Tests; Mutation; Repressor Proteins; Reverse Transcriptase Polymerase Chain Reaction; Staphylococcus aureus; Structure-Activity Relationship; Substrate Specificity | 2010 |
Prevalence and dissemination of oqxAB in Escherichia coli isolates from animals, farmworkers, and the environment.
Topics: Animals; Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; Escherichia coli Proteins; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Quinolones | 2010 |
QSAR-based solubility model for drug-like compounds.
Topics: Databases, Factual; Models, Molecular; Pharmaceutical Preparations; Quantitative Structure-Activity Relationship; Solubility; Water | 2010 |
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
Quinolone resistance in veterinary isolates of Salmonella.
Topics: Animals; Anti-Infective Agents; Chickens; Ciprofloxacin; Conjugation, Genetic; DNA, Bacterial; Drug Resistance, Microbial; Enrofloxacin; Fluoroquinolones; Lipopolysaccharides; Microbial Sensitivity Tests; Mutation; Nalidixic Acid; Poultry Diseases; Quinolones; Salmonella; Salmonella Infections, Animal; Turkeys | 1994 |
Quinolone accumulation by Pseudomonas aeruginosa, Staphylococcus aureus and Escherichia coli.
Topics: Anti-Infective Agents; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Ciprofloxacin; Diffusion; Dose-Response Relationship, Drug; Enoxacin; Enrofloxacin; Escherichia coli; Fluorescence; Fluoroquinolones; Hydrogen-Ion Concentration; Microbial Sensitivity Tests; Nalidixic Acid; Pseudomonas aeruginosa; Quinolones; Spheroplasts; Staphylococcus aureus; Temperature | 1999 |
Incidence of quinolone resistance over the period 1986 to 1998 in veterinary Salmonella isolates from Germany.
Topics: Animals; Anti-Infective Agents; Antineoplastic Agents; Cattle; Drug Resistance, Microbial; Enrofloxacin; Fluoroquinolones; Germany; Incidence; Microbial Sensitivity Tests; Nalidixic Acid; Poultry; Quinolones; Salmonella enterica; Salmonella Infections, Animal; Salmonella typhimurium; Serotyping; Swine | 1999 |
Characterization of high-level fluoroquinolone resistance in Escherichia coli O78:K80 isolated from turkeys.
Topics: Amino Acid Substitution; Animals; Anti-Infective Agents; Bacterial Proteins; Blotting, Western; Carrier Proteins; Ciprofloxacin; DNA Gyrase; DNA Topoisomerase IV; DNA Topoisomerases, Type II; DNA-Binding Proteins; DNA, Bacterial; Drug Resistance, Microbial; Enrofloxacin; Escherichia coli; Escherichia coli Proteins; Fluoroquinolones; Lipoproteins; Membrane Proteins; Membrane Transport Proteins; Microbial Sensitivity Tests; Multidrug Resistance-Associated Proteins; Mutation; Nalidixic Acid; Quinolizines; Quinolones; RNA, Ribosomal, 16S; RNA, Ribosomal, 23S; Turkeys | 2001 |
Epidemiological studies of human and animal Salmonella typhimurium DT104 and DT104b isolates in Ireland.
Topics: Animals; Anti-Infective Agents; Bacterial Typing Techniques; DNA, Bacterial; Drug Resistance, Microbial; Drug Resistance, Multiple; Electrophoresis, Gel, Pulsed-Field; Enrofloxacin; Fluoroquinolones; Humans; Ireland; Microbial Sensitivity Tests; Nalidixic Acid; Polymorphism, Restriction Fragment Length; Quinolones; Salmonella Infections; Salmonella Infections, Animal; Salmonella typhimurium | 2001 |
Quinolone resistance in potentially pathogenic and non-pathogenic Escherichia coli strains isolated from healthy ruminants.
Topics: Animals; Anti-Infective Agents; Cattle; Ciprofloxacin; Enrofloxacin; Escherichia coli; Fluoroquinolones; Goats; Microbial Sensitivity Tests; Nalidixic Acid; Quinolones; Ruminants; Sheep | 2001 |
Resistance to quinolones in Campylobacter jejuni and Campylobacter coli from Danish broilers at farm level.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Typing Techniques; Campylobacter coli; Campylobacter jejuni; Cephalothin; Culture Media; Denmark; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enrofloxacin; Fluoroquinolones; Microbial Sensitivity Tests; Nalidixic Acid; Poultry; Quinolones | 2003 |
In vivo selection of Campylobacter isolates with high levels of fluoroquinolone resistance associated with gyrA mutations and the function of the CmeABC efflux pump.
Topics: Animals; Anti-Infective Agents; Campylobacter Infections; Campylobacter jejuni; Chickens; Ciprofloxacin; DNA Gyrase; Drug Resistance, Microbial; Enrofloxacin; Fluoroquinolones; Microbial Sensitivity Tests; Mutation; Nalidixic Acid; Quinolones | 2003 |
Antimicrobial resistance in Campylobacter from broilers: association with production type and antimicrobial use.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Campylobacter coli; Campylobacter Infections; Campylobacter jejuni; Chickens; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Enrofloxacin; Erythromycin; Fluoroquinolones; Gentamicins; Microbial Sensitivity Tests; Nalidixic Acid; Polymerase Chain Reaction; Poultry Diseases; Quinolones; Tetracycline | 2003 |
Effect of a 5 day enrofloxacin treatment on Salmonella enterica serotype Typhimurium DT104 in the pig.
Topics: Animals; Anti-Bacterial Agents; Ciprofloxacin; Colony Count, Microbial; Cyclohexanes; DNA Gyrase; Drug Resistance, Bacterial; Enrofloxacin; Feces; Fluoroquinolones; Genes, Bacterial; Microbial Sensitivity Tests; Nalidixic Acid; Phenotype; Quinolones; Salmonella enterica; Salmonella Infections; Swine | 2004 |
Detection of mutations in the gyrA gene and class I integron from quinolone-resistant Salmonella enterica serovar Choleraesuis isolates in Taiwan.
Topics: Animals; Anti-Infective Agents; Base Sequence; DNA Gyrase; DNA, Bacterial; Drug Resistance, Bacterial; Enrofloxacin; Fluoroquinolones; Integrons; Molecular Sequence Data; Nalidixic Acid; Point Mutation; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Quinolones; Salmonella enterica; Salmonella Infections, Animal; Sequence Alignment; Swine; Swine Diseases; Taiwan | 2004 |
Single-nucleotide polymorphism mutation spectra and resistance to quinolones in Salmonella enterica serovar Enteritidis with a mutator phenotype.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Base Pair Mismatch; Chloramphenicol; Ciprofloxacin; DNA Gyrase; DNA Primers; DNA Probes; DNA Repair; DNA Topoisomerase IV; Drug Resistance, Bacterial; Enrofloxacin; Fluoroquinolones; Microbial Sensitivity Tests; Mutation; Nalidixic Acid; Phenotype; Polymorphism, Single Nucleotide; Quinolones; Salmonella enterica; Salmonella Infections | 2004 |
Effect of quinolone treatment on selection and persistence of quinolone-resistant Escherichia coli in swine faecal flora.
Topics: Administration, Oral; Animals; Anti-Infective Agents; Colony Count, Microbial; Culture Media; Drug Resistance, Bacterial; Enrofloxacin; Escherichia coli; Feces; Fluoroquinolones; Nalidixic Acid; Quinolones; Swine | 2005 |
Comparison of Campylobacter isolated from humans and food-producing animals in Japan.
Topics: Ampicillin; Animals; Anti-Infective Agents; Campylobacter; Campylobacter coli; Campylobacter jejuni; Cattle; Cluster Analysis; Dihydrostreptomycin Sulfate; Drug Resistance, Microbial; Electrophoresis, Gel, Pulsed-Field; Enrofloxacin; Erythromycin; Flagellin; Fluoroquinolones; Food Microbiology; Genes, Bacterial; Gentamicins; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Oxytetracycline; Poultry; Serotyping; Swine | 2006 |
Mutant prevention concentration of ciprofloxacin, enrofloxacin and nalidixic acid against Campylobacter jejuni.
Topics: Animals; Anti-Bacterial Agents; Campylobacter Infections; Campylobacter jejuni; Ciprofloxacin; Drug Resistance, Bacterial; Enrofloxacin; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Mutation; Nalidixic Acid; Poultry | 2008 |
Pheno- and genotypic analysis of antimicrobial resistance properties of Yersinia ruckeri from fish.
Topics: Animals; Anti-Infective Agents; Aquaculture; DNA Gyrase; Drug Resistance, Bacterial; Enrofloxacin; Fish Diseases; Fluoroquinolones; Germany, West; Microbial Sensitivity Tests; Nalidixic Acid; Oncorhynchus mykiss; Phenotype; Quinolones; Yersinia Infections; Yersinia ruckeri | 2014 |
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Carbapenems; Cephalosporins; Chloramphenicol; Colistin; Drug Resistance, Multiple; Enrofloxacin; Flavobacteriaceae Infections; Nalidixic Acid; Ornithobacterium; Oxacillin; Poultry Diseases; Tetracyclines; Turkeys; Tylosin | 2022 |